NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphoma.
about
Identification of C/EBPβ target genes in ALK+ anaplastic large cell lymphoma (ALCL) by gene expression profiling and chromatin immunoprecipitation.THOC5 spliceosome protein: a target for leukaemogenic tyrosine kinases that affects inositol lipid turnover.Next-generation sequencing identifies deregulation of microRNAs involved in both innate and adaptive immune response in ALK+ ALCL.Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes.C/EBPα, C/EBPα oncoproteins, or C/EBPβ preferentially bind NF-κB p50 compared with p65, focusing therapeutic targeting on the C/EBP:p50 interaction.The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK⁺ T-cell lymphomaThe CREB Coactivator CRTC2 Is a Lymphoma Tumor Suppressor that Preserves Genome Integrity through Transcription of DNA Mismatch Repair GenesPathobiology of ALK+ anaplastic large-cell lymphoma.Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR.C/EBPbeta regulates transcription factors critical for proliferation and survival of multiple myeloma cells.C/EBPβ expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway.Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transfer.EMMPRIN (CD147) is induced by C/EBPβ and is differentially expressed in ALK+ and ALK- anaplastic large-cell lymphoma.Concepts in mature T-cell lymphomas - highlights from an international joint symposium on T-cell immunology and oncology.Cyclin D1 positive diffuse large B-cell lymphoma is a post-germinal center-type lymphoma without alterations in the CCND1 gene locus.The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL).
P2860
Q34760541-A250C87D-B91B-4268-AB07-6DA4388CED58Q34765282-714D2781-AC04-4964-8C31-706DD5F39D1BQ35092068-043C32E3-36EE-40CE-BE06-7E8FE5ED32EAQ35131224-09C2A24A-7792-4675-8801-D15C83EA775BQ35387968-F5E24A10-28A5-4B65-B1BD-E8F93AE0082FQ35556180-2E4EE8D2-959B-46B0-9A05-C799188EE7B4Q35732828-D2F3DA2E-1B7B-4EE5-AE53-71E29003E093Q36007756-2FABD59A-4396-49A7-AC80-24536A4B28F4Q37406813-C52936A3-045F-4569-803C-0A6D24648A2FQ37412341-161724FF-830D-4EEB-93A6-75DF8B11F559Q39762430-E75A0647-3CBA-43B8-9A72-B7E887885319Q41818628-505A3F8F-9D8F-418B-ACD8-C9480C1565E1Q48328324-5E02D9C8-448F-4962-B6AD-FFE00DDC94E3Q48793063-E3F396DA-D06A-4E2C-A86D-DB19B0416E73Q52607553-6D4DA8DC-02D6-4802-8E05-996325FC33EBQ54117760-7EFBC6BA-7F8C-4B25-B445-62CE003B3F9E
P2860
NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
NPM-ALK-dependent expression o ...... naplastic large cell lymphoma.
@en
type
label
NPM-ALK-dependent expression o ...... naplastic large cell lymphoma.
@en
prefLabel
NPM-ALK-dependent expression o ...... naplastic large cell lymphoma.
@en
P2093
P50
P1433
P1476
NPM-ALK-dependent expression o ...... naplastic large cell lymphoma.
@en
P2093
Angelica Vivero
Antonio Martinez
Cornelius Miething
Elaine S Jaffe
Justus Duyster
Margit Klier
Mark Raffeld
Martina Rudelius
Natasa Anastasov
Stefania Pittaluga
P304
P356
10.1182/BLOOD-2005-10-014258
P407
P577
2006-05-18T00:00:00Z